Feedback / Questions
BFI-751 (ustekinumab biosimilar) - BioFactura
https://www.businesswire.com/news/home/20210525005574/en/BioFactura-Announces-Initiation-of-Phase-I-Study-of-BFI-751-a-Stelara%C2%AE-ustekinumab-Biosimilar
May 25, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next